Keynote Speakers
James Allison, Memorial Sloan-Kettering Cancer Center, USA
Rafi Ahmed, Emory University School of Medicine, USA
Martin Blaser, New York University School of Medicine, USA
Jean Laurent Casanova, The Rockefeller University, USA
Andrea Cerutti, Mount Sinai School of Medicine, USA
Mark Davis, Stanford University, USA
Frederic Geissmann, King’s College London, UK
Ronald Germain, National Institute of Allergy and Infectious Disease, USA
Jorg Goronzy, Stanford University, USA
Adrian Hayday, King’s College London, UK
Adrian Hill, University of Oxford, UK
Daniel Kastner, National Human Genome Research Institute, USA
Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Julie McElrath, Fred Hutchinson Cancer Research Center, USA
Luigi Notarangelo, Children’s Hospital Boston, USA
Anne O'Garra, MRC National Institute for Medical Research, UK
Anna Palucka, Baylor University, USA
Bali Pulendran, Emory University School of Medicine, USA
Rino Rappuoli, Novartis Vaccines, Italy
Federica Sallusto, Institute for Research in Biomedicine, Switzerland
Claire Anne Siegrist, Université de Genève, Switzerland
Bali Pulendran, Emory University School of Medicine, USA
Rino Rappuoli, Novartis Vaccines, Italy
Elena Porro, Cell Press
Peter Lee, Cell Press
Immunologists study the immune system to benefit human health, as a multitude of disorders ranging from cancer to infectious, autoimmune and metabolic diseases have an underlying basis rooted in immunity. Animal models have provided a tremendous amount of fundamental insight into the field of immunology. However, translating this knowledge to the clinic requires additional and direct appreciation of the human immune system.
With a wealth of information from animals and quantum leaps in technological advances, a renewed push for understanding the human immune system on a rapid time line is not only feasible, but also necessary.
We are bringing together scientists at the forefront of this endeavor to examine and discuss topics extending from innate and adaptive immunity to immunological understanding of cancer and vaccine using cutting-edge techniques that span genetics to systems approaches.
Our aim is to spur the progress of efforts to elucidate human immunity, which will in turn inform improvement in current vaccine design, disease treatments and maintenance of immune health.
